Profound LH suppression after GnRH antagonist administration is associated with a significantly higher ongoing pregnancy rate in IVF

92Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

Abstract

Background: The significance of suppressed LH levels in GnRH antagonist cycles for IVF outcome is currently unknown. The purpose of this study was to evaluate prospectively the association between LH levels and ongoing pregnancy achievement after GnRH antagonist initiation in IVF cycles. Methods: Ovarian stimulation with a fixed dose of 200 IU recombinant FSH and daily GnRH antagonist (ganirelix) 0.25 mg from day 6 of stimulation was initiated in 116 women. Patients were not pretreated with an oral contraceptive. Induction of final oocyte maturation was performed with HCG 10 000 IU as soon as three follicles of ≥17 mm were present in ultrasound, and was followed by oocyte pick-up, conventional IVF or ICSI, and embryo transfer. The luteal phase was supplemented with vaginal progesterone. Results: A significant decrease of both ongoing pregnancy rate and implantation rate was present across groups of patients with increasing LH levels. The highest implantation rate and ongoing pregnancy rate was present in those patients with LH levels on day 8 of stimulation ≤0.5 IU/l. Conclusions: Profound suppression of LH on day 8 of stimulation is associated with a significantly higher chance of achieving an ongoing pregnancy. More studies are necessary to evaluate this phenomenon further. © European Society of Human Reproduction and Embryology 2004; all rights reserved.

References Powered by Scopus

High fertilization and implantation rates after intracytoplasmic sperm injection

1162Citations
N/AReaders
Get full text

Reduced in‐vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase

403Citations
N/AReaders
Get full text

A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon®)

356Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The science behind 25 years of ovarian stimulation for in vitro fertilization

450Citations
N/AReaders
Get full text

A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists

295Citations
N/AReaders
Get full text

GnRH antagonists in ovarian stimulation for IVF

208Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Kolibianakis, E. M., Zikopoulos, K., Schiettecatte, J., Smitz, J., Tournaye, H., Camus, M., … Devroey, P. (2004). Profound LH suppression after GnRH antagonist administration is associated with a significantly higher ongoing pregnancy rate in IVF. Human Reproduction, 19(11), 2490–2496. https://doi.org/10.1093/humrep/deh471

Readers' Seniority

Tooltip

Professor / Associate Prof. 5

33%

PhD / Post grad / Masters / Doc 5

33%

Researcher 3

20%

Lecturer / Post doc 2

13%

Readers' Discipline

Tooltip

Medicine and Dentistry 14

70%

Agricultural and Biological Sciences 3

15%

Biochemistry, Genetics and Molecular Bi... 3

15%

Save time finding and organizing research with Mendeley

Sign up for free